Prolactin
For informational purposes only — not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen. Full disclaimer →
- Hyperprolactinemia is one of the most common and treatable causes of low testosterone in men — and is missed when prolactin isn't tested. A man with low testosterone, low libido, and fatigue who has never had prolactin measured has an incomplete workup. If elevated prolactin is suppressing his HPG axis, treating testosterone directly with exogenous TRT addresses the symptom while leaving the pituitary problem undiagnosed and untreated. A dopamine agonist (cabergoline or bromocriptine) often normalizes testosterone and reverses all symptoms without the need for testosterone replacement.
- Dopamine agonists used to treat prolactinoma are also among the most well-studied longevity compounds in animal models. Cabergoline, the primary treatment for prolactinoma, is a dopamine D2 receptor agonist. Separately from its prolactin-lowering effects, dopamine agonism has shown life-extension effects in multiple animal model studies, and dopaminergic signaling is an active area of longevity research. Some longevity-focused practitioners use low-dose cabergoline in people without prolactinoma — this is an experimental application distinct from its standard therapeutic use.
- Many common medications silently elevate prolactin — and this effect is rarely discussed with patients. Antipsychotic medications (both typical and many atypical agents), some antidepressants (particularly those with dopamine-blocking properties), metoclopramide (a common antiemetic), and several antihypertensive medications all inhibit dopamine signaling and raise prolactin. Patients on these medications often develop low libido, sexual dysfunction, menstrual irregularities, or galactorrhea — effects that may be attributed to the underlying condition being treated rather than the medication. Measuring prolactin in anyone on these medications is clinically informative.
- Prolactin connects to the immune system in ways that are relevant to aging. Prolactin receptors are expressed on T cells, B cells, and natural killer cells, and prolactin modulates immune function. Chronically elevated prolactin has immunostimulatory effects, and hyperprolactinemia has been associated with increased autoimmune activity in several conditions. Conversely, very low prolactin (which can occur with pituitary insufficiency) is associated with reduced immune competence. The clinical significance of these immune effects in the context of longevity medicine is still being defined.
- Prolactin and testosterone form a see-saw relationship in men. Dopamine normally suppresses prolactin while also supporting gonadotropin-releasing hormone (GnRH) pulsatility and testosterone production. Conditions that reduce dopamine tone — stress, sleep deprivation, certain medications, dopamine-depleting neurotoxins — simultaneously raise prolactin and reduce testosterone through this shared regulatory pathway. This mechanistic linkage explains why hyperprolactinemia so reliably and specifically produces hypogonadal symptoms in men.
The Hormone Most Commonly Left Off the Panel
A man presents to his internist with fatigue, reduced libido, and difficulty maintaining erections. Total testosterone comes back at 280 ng/dL — low-normal to low. His doctor orders a repeat testosterone, a PSA, and maybe SHBG. If all three look concerning, he's referred to urology or started on testosterone replacement therapy.
What is almost never ordered: prolactin.
This is a systematic gap in standard care that has real consequences. Hyperprolactinemia — elevated prolactin from a pituitary microadenoma, medication effect, or hypothyroidism — is a meaningful cause of secondary hypogonadism. It suppresses the HPG axis, reduces LH and FSH output, and drives down testosterone. The symptoms are identical to primary hypogonadism from any other cause. Without measuring prolactin, the pituitary origin is invisible.
The treatment implications differ substantially. A man with primary hypogonadism may need exogenous testosterone. A man with secondary hypogonadism from a prolactinoma can often have his testosterone fully normalized by a dopamine agonist (cabergoline) — no exogenous hormones required, the underlying cause addressed directly. Starting TRT in a man with an undiagnosed prolactinoma leaves the pituitary problem untreated and, more importantly, misses a condition that may need its own monitoring and management.
Prolactin and the HPG Axis: The Dopamine Connection
Understanding why elevated prolactin suppresses testosterone requires understanding the hormone's regulatory architecture.
Prolactin secretion from the pituitary is tonically inhibited by dopamine, which is released from hypothalamic neurons and travels to the anterior pituitary via the hypothalamic-hypophyseal portal system. When dopamine reaches pituitary lactotrophs, it binds to D2 receptors and suppresses prolactin release. This is the default state: dopamine holds prolactin down.
The same dopamine neurons that inhibit prolactin also facilitate GnRH (gonadotropin-releasing hormone) pulsatility — the upstream driver of LH and FSH release, which in turn drives gonadal testosterone production. When dopamine signaling is disrupted, both effects occur simultaneously: prolactin rises as dopamine inhibition is removed, and GnRH pulsatility falls as dopamine's facilitatory input is lost. The result is simultaneous hyperprolactinemia and hypogonadism through a shared mechanism.
This architecture explains the remarkably specific and consistent symptom profile of hyperprolactinemia in men: low testosterone, low libido, erectile dysfunction, reduced spermatogenesis, and sometimes galactorrhea — all originating from a single upstream disruption in hypothalamic dopamine signaling. 1
| Population | Standard Range | Longevity Optimal | Notes |
|---|---|---|---|
| Men | 2–18 ng/mL | 3–12 ng/mL | Above 18 warrants repeat + medication review |
| Women (non-pregnant) | 2–29 ng/mL | 3–20 ng/mL | Ranges vary with menstrual phase |
| Pregnant women | Up to 400 ng/mL | N/A — physiologic elevation | Rises progressively through pregnancy |
| Either (>150 ng/mL) | Markedly elevated | Strongly suggests prolactinoma | Pituitary MRI indicated |
| Range Type | Value (ng/mL) | Notes |
|---|---|---|
| Standard Clinical Range | Men: 2–18 ng/mL · Women (non-pregnant): 2–29 ng/mL · Pregnancy: up to 400 ng/mL | Designed to identify disease risk — not longevity optimisation. |
| Longevity-Optimal Target | Men: 3–12 ng/mL · Women (non-pregnant): 3–20 ng/mL |
Associated with reduced all-cause mortality and extended healthspan.
Mildly elevated prolactin (above the upper reference limit but below 100–150 ng/mL) can reflect a microadenoma, medication effect, or hypothyroidism. Values above 150–200 ng/mL are strongly associated with prolactinoma and warrant pituitary MRI. Very high prolactin values (>500 ng/mL) are almost always due to a macroprolactinoma. Before attributing elevated prolactin to pathology, medication review is essential — over 100 drugs can cause hyperprolactinemia, most commonly dopamine antagonists. TSH should always be checked alongside prolactin since hypothyroidism (elevated TRH) is a common secondary cause of mild prolactin elevation. Prolactin shows significant episodic secretion and rises with stress, recent sexual activity, and the first 30–60 minutes after waking — fasting morning blood draws after a brief rest period provide the most stable measurements.
|
Already have your results? See what your Prolactin and other markers reveal about your longevity in 60 seconds.
Analyze My Labs →Affiliate disclosure: we may earn a commission if you purchase through these links at no extra cost to you.
When should prolactin be included in a hormonal workup?
Prolactin should be included whenever the clinical picture suggests possible pituitary involvement or HPG axis suppression. For men, this means any evaluation for low testosterone or hypogonadism — a low testosterone workup that does not include prolactin is incomplete. For women, it should be included in evaluations for irregular periods, anovulation, or unexplained infertility. For anyone experiencing galactorrhea (spontaneous milk production or nipple discharge outside of pregnancy/breastfeeding), prolactin testing is essential. In people on medications known to elevate prolactin (antipsychotics, some antidepressants, metoclopramide), baseline and follow-up prolactin measurements are clinically useful. In anyone with headaches, visual disturbances, or visual field changes combined with any hormonal symptoms, pituitary pathology including prolactinoma should be considered and prolactin tested. As part of a general longevity panel for men and women over 35, prolactin adds relatively low incremental cost but meaningful diagnostic value — particularly given how commonly mild elevation is caused by treatable and modifiable causes.
What is a prolactinoma and how common is it?
A prolactinoma is a benign pituitary tumor (adenoma) composed of prolactin-secreting lactotroph cells — the most common type of functional pituitary tumor, accounting for approximately 40% of all pituitary adenomas. They are classified by size: microadenomas are less than 10 mm in diameter; macroadenomas are 10 mm or larger. Microadenomas are far more common and are often discovered incidentally when prolactin is measured for another reason. Prolactinomas are found in approximately 1 in 1,000 people in population-based imaging studies, making them meaningfully prevalent. The clinical significance depends on size and prolactin level: microadenomas causing mild hyperprolactinemia primarily affect hormonal and reproductive function; macroadenomas can additionally cause mass effects including headaches, vision impairment (particularly bitemporal visual field loss from optic chiasm compression), and hypopituitarism from compression of surrounding pituitary tissue. Treatment with dopamine agonists (cabergoline) effectively shrinks most prolactinomas and normalizes prolactin in over 90% of cases.
What medications cause elevated prolactin and what should I do about it?
Drug-induced hyperprolactinemia is the most common cause of elevated prolactin outside of pregnancy. The primary culprits are medications that block or deplete dopamine: typical antipsychotics (haloperidol, chlorpromazine), many atypical antipsychotics (risperidone, amisulpride — notably, quetiapine, aripiprazole, and clozapine have minimal prolactin effect), metoclopramide and domperidone (antiemetics), some antidepressants (particularly those with D2 receptor affinity), methyldopa, reserpine, and verapamil. If you're on one of these medications and have hormonal symptoms (low libido, menstrual irregularities, sexual dysfunction, galactorrhea), measuring prolactin is warranted. If medication-induced hyperprolactinemia is confirmed, the ideal solution is switching to an alternative medication without prolactin-elevating effects, if clinically feasible. This should always be done in consultation with the prescribing physician — never stop psychiatric or other medications independently.
Why does prolactin rise with stress and what does that mean for testing?
Stress activates the hypothalamic-pituitary-adrenal axis, and psychological and physical stress both transiently elevate prolactin — likely through stress-mediated inhibition of hypothalamic dopamine neurons. Physical stress from blood drawing (venipuncture anxiety), breast examination, sexual activity in the preceding hours, and even the first hour after waking all transiently raise prolactin. Prolactin also secretes in pulses throughout the day with a nocturnal peak during sleep. These sources of variability mean that a single elevated prolactin reading should be confirmed with a repeat measurement under standardized conditions: fasting morning blood draw, after at least 30–60 minutes of quiet rest in the phlebotomy area before the draw, with no strenuous exercise in the prior 24 hours. Confirming elevation on a second draw before proceeding with further workup avoids unnecessary concern from transient elevations.